Fujitsu develops supercomputer system for Taiwan’s Central Weather Bureau for numerical weather forecasting

TOKYO, Jan 17, 2023 – (JCN Newswire via SEAPRWire.com) – Fujitsu today announced the development of a supercomputer system for Taiwan’s Central Weather Bureau (hereinafter CWB)(1) for use in numerical weather predictions. The new system started operation in June 2022 under an initiative that was initially implemented in 2021. The program will be extended in […]

MHI Signs MoU to Collaborate in Feasibility Studies on Ammonia Co-Firing for Power Generation in BLCP Power Station

TOKYO, Jan 16, 2023 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries, Ltd. (MHI) signed a Memorandum of Understanding (MoU) to collaborate in a feasibility study for the introduction of ammonia co-firing at a coal-fired thermal power plant operated by BLCP Power Limited (BLCP), which is an independent power producer (IPP) in Thailand and […]

Fujitsu and Sapporo Medical University launch joint project to realize data portability in the healthcare field

TOKYO, Jan 16, 2023 – (JCN Newswire via SEAPRWire.com) – Fujitsu and Sapporo Medical University today announced the launch of a joint project starting in April 2023 to realize data portability (1) for patients’ healthcare data including electronic health records (EHRs) (2) and personal health records (PHRs) (3). Image 1: Overview of the initiative Image […]

Mazda reveals Mazda MX-30 e-Skyactiv R-EV in Europe

HIROSHIMA, Japan, Jan 16, 2023 – (JCN Newswire via SEAPRWire.com) – Mazda Motor Corporation unveiled the Mazda MX-30 e-Skyactiv R-EV, a plug-in hybrid model that uses a rotary engine as a generator, at the Brussels Motor Show(1) today. The leading product for Mazda electrification, the Mazda MX-30 launched in 2020 as Mazda’s first mass-production battery […]

Eisai Launches Renewed Sustainability Page

TOKYO, Jan 13, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced that it has renewed the Sustainability page of its corporate website and it is now accessible to the public. Sustainability Top Pagewww.eisai.com/sustainability/index.html The Eisai’s Corporate Concept is “to give first thought to patients and the people in the daily living domain, […]

Research commenced with Keio University to discover drugs using “Chemicals Informatics”

TOKYO, Jan 12, 2023 – (JCN Newswire via SEAPRWire.com) – Hitachi High-Tech Solutions Corporation, in collaboration with Keio University Faculty of Pharmacy, Department of Pharmaceutical Sciences is commencing joint research that uses Materials Informatics (MI) (the Research) to improve the efficiency of the development of small molecule drugs(1). Hitachi High-Tech Solutions will be using the […]

Eisai Submits Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease in Europe

TOKYO, Jan 11, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Eisai has submitted a marketing authorization application (MAA) for lecanemab (Brand Name in the U.S.: LEQEMBI), an investigational anti-amyloid beta (Abeta) protofibril antibody, for the treatment of early Alzheimer’s disease (mild cognitive impairment due […]

MHI Thermal Systems Adds ZTL Series to Its Lineup of Household Room Air Conditioners for Overseas Markets

TOKYO, Jan 10, 2023 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Heavy Industries Thermal Systems, Ltd. (MHI Thermal Systems), a part of Mitsubishi Heavy Industries (MHI) Group, has added the new ZTL Series to its lineup of household room air conditioners for overseas markets, and the mass production of small capacity models (1.5kW~5.0kW) for the […]

Toyota Launches All-New Prius HEV in Japan

Toyota City, Japan, Jan 10, 2023 – (JCN Newswire via SEAPRWire.com) – Toyota Motor Corporation (Toyota) announces today that it has commenced sales of all-new Prius Series Parallel Hybrid (HEV) models. It will also launch Plug-in Hybrid (PHEV) models around March this year. Launched in 1997 as the world’s first mass-produced hybrid car, the Prius […]

Eisai Submits Supplemental Biologics License Application to FDA for Traditional Approval of LEQEMBI (lecanemab-irmb) for the Treatment of Alzheimer’s Disease

TOKYO, Jan 9, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced Eisai has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) supporting the conversion of the Accelerated Approval of LEQEMBI (lecanemab-irmb) 100 mg/mL injection for intravenous use to a traditional approval. This […]

FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer’s Disease

TOKYO and CAMBRIDGE, Mass., Jan 9, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that under the Accelerated Approval Pathway the U.S. Food and Drug Administration (FDA) has approved lecanemab-irmb (Brand Name in the U.S.: LEQEMBI) 100 mg/mL injection for intravenous use, a humanized immunoglobulin gamma 1 (IgG1) […]